首页 > 最新文献

Asian journal of psychiatry最新文献

英文 中文
National study comparing psychiatric presentations among migrants and citizens in Qatar 比较卡塔尔移民和公民精神病发病情况的全国性研究
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104200

Arab countries host 10 % of the global migrant population, yet research on the mental health of migrant workers within this region is notably lacking. Addressing this gap, our study marks the inaugural nationwide investigation into psychiatric conditions among migrant workers compared to native Qatari citizens in an inpatient setting. Employing a retrospective cohort methodology, we scrutinized psychiatric presentations among two cohorts: migrant workers (cohort 1) and Qatari nationals (cohort 2) admitted to psychiatric inpatient facilities in Qatar. Our sample comprised 150 migrant workers and 138 Qatari inpatients, with a predominance of males in both cohorts and mean ages around 34–35 years. The median length of hospitalization was 13 days for migrant workers and 14 days for Qatari patients. Qatari inpatients exhibited a higher prevalence of prior psychiatric history and comorbid physical conditions. The primary diagnosis upon discharge for approximately one-third of patients in both groups was schizophrenia spectrum and other psychotic disorders, with bipolar disorder representing roughly one-quarter of cases in each cohort. Notably, migrant workers demonstrated a higher incidence of depressive disorders, trauma, and stress-related conditions, while Qatari patients were more frequently diagnosed with substance use disorder and displayed aggressive behaviors.

阿拉伯国家的移民人口占全球移民人口的 10%,但有关该地区移民工人心理健康的研究却明显不足。为了填补这一空白,我们的研究首次在全国范围内调查了住院病人中外来务工人员与卡塔尔本地公民的精神状况。我们采用回顾性队列方法,仔细研究了两个队列中的精神病症状:在卡塔尔精神病院住院的外来务工人员(队列 1)和卡塔尔国民(队列 2)。我们的样本包括 150 名外来务工人员和 138 名卡塔尔住院病人,两组病人均以男性为主,平均年龄约为 34-35 岁。外来务工人员的住院时间中位数为 13 天,卡塔尔患者的住院时间中位数为 14 天。卡塔尔住院病人有精神病史和合并症的比例较高。两组患者中约有三分之一出院时的主要诊断是精神分裂症谱系和其他精神病性障碍,双相情感障碍约占两组病例的四分之一。值得注意的是,外来务工人员抑郁症、精神创伤和压力相关疾病的发病率较高,而卡塔尔病人则更常被诊断为药物使用障碍和攻击行为。
{"title":"National study comparing psychiatric presentations among migrants and citizens in Qatar","authors":"","doi":"10.1016/j.ajp.2024.104200","DOIUrl":"10.1016/j.ajp.2024.104200","url":null,"abstract":"<div><p>Arab countries host 10 % of the global migrant population, yet research on the mental health of migrant workers within this region is notably lacking. Addressing this gap, our study marks the inaugural nationwide investigation into psychiatric conditions among migrant workers compared to native Qatari citizens in an inpatient setting. Employing a retrospective cohort methodology, we scrutinized psychiatric presentations among two cohorts: migrant workers (cohort 1) and Qatari nationals (cohort 2) admitted to psychiatric inpatient facilities in Qatar. Our sample comprised 150 migrant workers and 138 Qatari inpatients, with a predominance of males in both cohorts and mean ages around 34–35 years. The median length of hospitalization was 13 days for migrant workers and 14 days for Qatari patients. Qatari inpatients exhibited a higher prevalence of prior psychiatric history and comorbid physical conditions. The primary diagnosis upon discharge for approximately one-third of patients in both groups was schizophrenia spectrum and other psychotic disorders, with bipolar disorder representing roughly one-quarter of cases in each cohort. Notably, migrant workers demonstrated a higher incidence of depressive disorders, trauma, and stress-related conditions, while Qatari patients were more frequently diagnosed with substance use disorder and displayed aggressive behaviors.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876201824002934/pdfft?md5=9fa14bb68b5d62afb20fe13321319f66&pid=1-s2.0-S1876201824002934-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secular trends in the prevalence of schizophrenia among different age, period and cohort groups between 1990 and 2019 1990 年至 2019 年不同年龄、时期和队列组精神分裂症患病率的长期趋势
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104192

Background

Schizophrenia remains a major public health challenge, and designing efforts to manage it requires understanding its prevalence over time at different geographic scales and population groups.

Methods

Drawing on data from the Global Burden of Disease study 2019, annual percentage change of schizophrenia was assessed across different age, period and cohort groups at different geographic scales from 1990 to 2019. We examined associations of prevalence with the sociodemographic index.

Results

Global prevalence of schizophrenia in 2019 was 23.60 million (95 % uncertainty interval: 20.23–27.15), with China, India, the USA and Indonesia accounting for 50.72 % of it. Global prevalence increased slightly from 1990 to 2019, with an annual percentage change of 0.03 % (95 % confidence interval 0.01–0.05). Regions with intermediate sociodemographic index accounted for greater proportion of prevalence increasing than regions with high index. Prevalence decreased among those born after 1979 in regions with intermediate sociodemographic index, whereas it consistently improved among all birth cohorts in regions with low index. Regardless of sociodemographic index, prevalence was highest among individuals 30–59 years old than younger or older groups.

Conclusions

Prevalence of schizophrenia has shown small increases globally over the last three decades. The burden of disease is heavier in relatively less affluent regions, and it disproportionately affects individuals 30–59 years in all regions. Meanwhile, for regions with lower sociodemographic indices, the recent increasing burden among birth cohorts is more pronounced. These findings may help guide futural design of measures to manage or prevent schizophrenia in communities at higher risk.

背景精神分裂症仍然是一项重大的公共卫生挑战,要想设计出管理精神分裂症的方法,就必须了解其在不同地域范围和人群中的患病率。方法利用2019年全球疾病负担研究(Global Burden of Disease study 2019)的数据,评估了1990年至2019年不同地域范围内不同年龄、时期和队列组的精神分裂症年度百分比变化。结果2019年全球精神分裂症患病率为2360万(95%不确定区间:2023-2715),其中中国、印度、美国和印度尼西亚占50.72%。从 1990 年到 2019 年,全球患病率略有上升,年百分比变化为 0.03 %(95 % 置信区间:0.01-0.05)。与高指数地区相比,中等社会人口指数地区的患病率增长比例更大。在社会人口指数处于中等水平的地区,1979 年后出生的人群的患病率有所下降,而在社会人口指数较低的地区,所有出生人群的患病率均有所上升。无论社会人口指数如何,30-59 岁人群的患病率均高于年轻或年长人群。在相对不富裕的地区,疾病负担更重,而且在所有地区,30-59 岁人群的发病率都不成比例。与此同时,在社会人口指数较低的地区,出生组群中近来不断增加的负担更为明显。这些发现可能有助于指导今后在高风险社区设计管理或预防精神分裂症的措施。
{"title":"Secular trends in the prevalence of schizophrenia among different age, period and cohort groups between 1990 and 2019","authors":"","doi":"10.1016/j.ajp.2024.104192","DOIUrl":"10.1016/j.ajp.2024.104192","url":null,"abstract":"<div><h3>Background</h3><p>Schizophrenia remains a major public health challenge, and designing efforts to manage it requires understanding its prevalence over time at different geographic scales and population groups.</p></div><div><h3>Methods</h3><p>Drawing on data from the Global Burden of Disease study 2019, annual percentage change of schizophrenia was assessed across different age, period and cohort groups at different geographic scales from 1990 to 2019. We examined associations of prevalence with the sociodemographic index.</p></div><div><h3>Results</h3><p>Global prevalence of schizophrenia in 2019 was 23.60 million (95 % uncertainty interval: 20.23–27.15), with China, India, the USA and Indonesia accounting for 50.72 % of it. Global prevalence increased slightly from 1990 to 2019, with an annual percentage change of 0.03 % (95 % confidence interval 0.01–0.05). Regions with intermediate sociodemographic index accounted for greater proportion of prevalence increasing than regions with high index. Prevalence decreased among those born after 1979 in regions with intermediate sociodemographic index, whereas it consistently improved among all birth cohorts in regions with low index. Regardless of sociodemographic index, prevalence was highest among individuals 30–59 years old than younger or older groups.</p></div><div><h3>Conclusions</h3><p>Prevalence of schizophrenia has shown small increases globally over the last three decades. The burden of disease is heavier in relatively less affluent regions, and it disproportionately affects individuals 30–59 years in all regions. Meanwhile, for regions with lower sociodemographic indices, the recent increasing burden among birth cohorts is more pronounced. These findings may help guide futural design of measures to manage or prevent schizophrenia in communities at higher risk.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142129259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussion, implications, and recommendations of several alternative interventions to intervene suicidal ideation in youth with autism spectrum disorder 关于干预自闭症谱系障碍青少年自杀意念的几种替代干预方法的讨论、影响和建议
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104196

The purpose of this article is to provide an additional point of view containing discussion, implications, and recommendations for intervention to autistic persons who have suicidal ideation and behavior. Therefore, the author hopes that this article can complement reports on several previous studies that have had an extraordinary impact.

本文旨在提供一个新的视角,包含对有自杀意念和行为的自闭症患者进行干预的讨论、影响和建议。因此,作者希望这篇文章能对之前几项影响非凡的研究报告起到补充作用。
{"title":"Discussion, implications, and recommendations of several alternative interventions to intervene suicidal ideation in youth with autism spectrum disorder","authors":"","doi":"10.1016/j.ajp.2024.104196","DOIUrl":"10.1016/j.ajp.2024.104196","url":null,"abstract":"<div><p>The purpose of this article is to provide an additional point of view containing discussion, implications, and recommendations for intervention to autistic persons who have suicidal ideation and behavior. Therefore, the author hopes that this article can complement reports on several previous studies that have had an extraordinary impact.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142122577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 12-year comparison of patients with Alzheimer’s dementia with their informants in eight Asian countries 八个亚洲国家阿尔茨海默氏症痴呆症患者与其信息提供者 12 年的对比研究。
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104204

Background

The number of patients with Alzheimer’s disease (AD) has increased dramatically in Asia.

Objective

To update the demographic characteristics of patients with AD and their informants in eight Asian countries and compare them from 12 years prior.

Methods

The A1–A3 components of the Uniform Dataset (UDS), version 3.0, were administered in Taiwan, Beijing, Hong Kong, Korea, Japan, Philippines, Thailand, and Indonesia. Data were compared with patients with AD in the first registration using the UDS version 1.0 from 2010–2014 in the same regions.

Results

A total of 1885 patients with AD and their informants were recruited from 2022 to 2024 and were compared with 2042 patients recruited a decade prior. Each country had its own unique characteristics that changed between both eras. The mean age of the patients and informants was 79.8±8.2 years and 56.5±12.1 years, respectively. Compared with the first registration, the patients were older (79.8 vs 79.0, p=0.002) and had worse global function (mean CDR-SB scores 6.1 vs 5.8, p<0.001); more informants were children (56 % vs. 48 %, p<0.001), and their frequency of in-person visits increased significantly if not living together. A total of 11 %, 4.5 %, 11 %, and 0.4 % of the patients had a reported history of cognitive impairment in their mothers, fathers, siblings, and children, respectively; all percentages, except children, increased significantly over the past decade.

Conclusion

The present study reports the heterogeneous characteristics of patients with AD and their informants in Asian countries, and the distinct changes in the past decade. The differences in dementia evaluation and care between developing and developed countries warrant further investigation.

背景亚洲阿尔茨海默病患者的人数急剧增加:更新八个亚洲国家阿尔茨海默病患者及其信息提供者的人口统计学特征,并与 12 年前进行比较:方法:在台湾、北京、香港、韩国、日本、菲律宾、泰国和印度尼西亚进行了统一数据集(UDS)3.0 版 A1-A3 部分的调查。数据与2010-2014年在同一地区使用UDS 1.0版首次登记的AD患者进行了比较:结果:从2022年到2024年,共招募了1885名AD患者及其信息提供者,并与十年前招募的2042名患者进行了比较。每个国家都有自己独特的特征,这两个时代之间也有所变化。患者和信息提供者的平均年龄分别为(79.8±8.2)岁和(56.5±12.1)岁。与首次登记相比,患者年龄更大(79.8 vs 79.0,P=0.002),整体功能更差(CDR-SB 平均分 6.1 vs 5.8,P=0.002):本研究报告了亚洲国家注意力缺失症患者及其信息提供者的不同特征,以及过去十年间的显著变化。发展中国家和发达国家在痴呆症评估和护理方面的差异值得进一步研究。
{"title":"A 12-year comparison of patients with Alzheimer’s dementia with their informants in eight Asian countries","authors":"","doi":"10.1016/j.ajp.2024.104204","DOIUrl":"10.1016/j.ajp.2024.104204","url":null,"abstract":"<div><h3>Background</h3><p>The number of patients with Alzheimer’s disease (AD) has increased dramatically in Asia.</p></div><div><h3>Objective</h3><p>To update the demographic characteristics of patients with AD and their informants in eight Asian countries and compare them from 12 years prior.</p></div><div><h3>Methods</h3><p>The A1–A3 components of the Uniform Dataset (UDS), version 3.0, were administered in Taiwan, Beijing, Hong Kong, Korea, Japan, Philippines, Thailand, and Indonesia. Data were compared with patients with AD in the first registration using the UDS version 1.0 from 2010–2014 in the same regions.</p></div><div><h3>Results</h3><p>A total of 1885 patients with AD and their informants were recruited from 2022 to 2024 and were compared with 2042 patients recruited a decade prior. Each country had its own unique characteristics that changed between both eras. The mean age of the patients and informants was 79.8±8.2 years and 56.5±12.1 years, respectively. Compared with the first registration, the patients were older (79.8 vs 79.0, <em>p</em>=0.002) and had worse global function (mean CDR-SB scores 6.1 vs 5.8, <em>p</em>&lt;0.001); more informants were children (56 % vs. 48 %, <em>p</em>&lt;0.001), and their frequency of in-person visits increased significantly if not living together. A total of 11 %, 4.5 %, 11 %, and 0.4 % of the patients had a reported history of cognitive impairment in their mothers, fathers, siblings, and children, respectively; all percentages, except children, increased significantly over the past decade.</p></div><div><h3>Conclusion</h3><p>The present study reports the heterogeneous characteristics of patients with AD and their informants in Asian countries, and the distinct changes in the past decade. The differences in dementia evaluation and care between developing and developed countries warrant further investigation.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142144933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal emotion regulation abilities affect adolescent depressive symptoms by mediating their emotion regulation ability: An ERP study 母亲的情绪调节能力会影响青少年的抑郁症状:ERP研究
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104190

Adolescents with major depressive disorder (MDD) experience significant difficulties in emotion regulation. This study aimed to explore emotion regulation in adolescents with depression using an emotion regulation paradigm combined with event-related potentials (ERP) while investigating the relationship between maternal emotion regulation and adolescent depressive symptoms through a mediation model. Overall, 38 healthy controls (HC) and 57 adolescents with depression (MDD) rated the pictures they saw according to aversive reappraisal (reappraisal of an aversive picture or down-regulate aversive emotions), aversive watch, and neutral conditions. Adolescents with depression gave more negative ratings to aversive images, and the emotional regulation success index (ERSI) of adolescents with depression was lower than that of healthy individuals. ERP data revealed an elevation in late positive potential (LPP) amplitude during the aversive reappraisal and aversive watch conditions compared with that in the neutral condition in the MDD group. Compared with the HC group, adolescents with depression showed larger LPP amplitudes under aversive watch conditions. The aversive reappraisal condition evoked a larger LPP than that in the other conditions in the HC group in the late time windows. The ΔLPP (separating the variability in the ERP wave associated with emotion regulation) was larger in the HC group than in the MDD group. Mediation analysis revealed that maternal emotion regulation influenced adolescent depression levels through its effect on the adolescent’s emotion regulation. These findings provide important insights into the emotion regulation process in adolescents with depression and offer suggestions for clinical interventions.

患有重度抑郁症(MDD)的青少年在情绪调节方面会遇到很大困难。本研究旨在使用情绪调节范式结合事件相关电位(ERP)来探讨抑郁症青少年的情绪调节,同时通过中介模型研究母亲情绪调节与青少年抑郁症状之间的关系。总体而言,38 名健康对照组(HC)和 57 名抑郁症青少年(MDD)按照厌恶性重评(重评厌恶性图片或下调厌恶性情绪)、厌恶性观察和中性条件对他们看到的图片进行了评分。患有抑郁症的青少年对厌恶性图片给予了更多的负面评价,而患有抑郁症的青少年的情绪调节成功指数(ERSI)低于健康人。ERP数据显示,在厌恶重评和厌恶观看条件下,MDD组的晚期正电位(LPP)振幅比中性条件下的振幅高。与HC组相比,抑郁症青少年在厌恶观察条件下的LPP振幅更大。在晚期时间窗,厌恶性再评价条件下的 LPP 比 HC 组其他条件下的 LPP 更大。与 MDD 组相比,HC 组的ΔLPP(分离与情绪调节相关的 ERP 波的变异性)更大。中介分析显示,母亲的情绪调节通过对青少年情绪调节的影响来影响青少年的抑郁水平。这些发现为了解青少年抑郁症患者的情绪调节过程提供了重要启示,并为临床干预提供了建议。
{"title":"Maternal emotion regulation abilities affect adolescent depressive symptoms by mediating their emotion regulation ability: An ERP study","authors":"","doi":"10.1016/j.ajp.2024.104190","DOIUrl":"10.1016/j.ajp.2024.104190","url":null,"abstract":"<div><p>Adolescents with major depressive disorder (MDD) experience significant difficulties in emotion regulation. This study aimed to explore emotion regulation in adolescents with depression using an emotion regulation paradigm combined with event-related potentials (ERP) while investigating the relationship between maternal emotion regulation and adolescent depressive symptoms through a mediation model. Overall, 38 healthy controls (HC) and 57 adolescents with depression (MDD) rated the pictures they saw according to aversive reappraisal (reappraisal of an aversive picture or down-regulate aversive emotions), aversive watch, and neutral conditions. Adolescents with depression gave more negative ratings to aversive images, and the emotional regulation success index (ERSI) of adolescents with depression was lower than that of healthy individuals. ERP data revealed an elevation in late positive potential (LPP) amplitude during the aversive reappraisal and aversive watch conditions compared with that in the neutral condition in the MDD group. Compared with the HC group, adolescents with depression showed larger LPP amplitudes under aversive watch conditions. The aversive reappraisal condition evoked a larger LPP than that in the other conditions in the HC group in the late time windows. The ΔLPP (separating the variability in the ERP wave associated with emotion regulation) was larger in the HC group than in the MDD group. Mediation analysis revealed that maternal emotion regulation influenced adolescent depression levels through its effect on the adolescent’s emotion regulation. These findings provide important insights into the emotion regulation process in adolescents with depression and offer suggestions for clinical interventions.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142238816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond mothers: Postpartum depression among fathers in Pakistan 母亲之外:巴基斯坦父亲的产后抑郁症
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104213
{"title":"Beyond mothers: Postpartum depression among fathers in Pakistan","authors":"","doi":"10.1016/j.ajp.2024.104213","DOIUrl":"10.1016/j.ajp.2024.104213","url":null,"abstract":"","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global burden of ADHD medication-associated cardiovascular disease, 1967–2023: A comparative analysis using the WHO pharmacovigilance database 1967-2023年ADHD药物相关心血管疾病的全球负担:利用世界卫生组织药物警戒数据库进行比较分析。
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104209

Background

Despite the widespread use of attention-deficit hyperactivity disorder (ADHD) medications and their known sympathomimetic effects on the cardiovascular system, cardiovascular risk assessment of these medications using comprehensive global data is limited. This study investigated the association between individual ADHD medications and cardiovascular disease (CVD) using global pharmacovigilance data.

Methods

Reports from the World Health Organization international pharmacovigilance database were utilized (1967–2023; total reports, n=131,255,418). Reporting odds ratios (ROR), and information components (IC) were calculated to evaluate the association between each medication and specific CVDs.

Results

We identified 13,344 CVD cases related to ADHD medications out of 146,489 cases of all reports on ADHD medications. Cumulative reports on ADHD medications have shown a steady increase, notably in adults since 2010. ADHD medications were associated with a higher risk of CVD overall (ROR [95 % CI], 1.60 [1.58–1.63]; IC [IC0.25], 0.63 [0.60]), with a higher association observed in females than in males. Among specific CVDs, all drugs were associated with an increased risk of torsade de pointes/QT prolongation, cardiomyopathy, and myocardial infarction. Conversely, heart failure, stroke, and cardiac death/shock were exclusively associated with amphetamines. Lisdexamfetamine showed a weaker association with all CVDs compared to amphetamines, and methylphenidate exhibited the lowest overall association with CVD. Atomoxetine had the second-highest association with torsade de pointes/QT prolongation.

Conclusions

The associations between CVDs and ADHD medications vary, with amphetamines posing a higher risk, while lisdexamfetamine and methylphenidate exhibit better safety profiles.

背景:尽管注意力缺陷多动障碍(ADHD)药物被广泛使用,而且其对心血管系统的拟交感作用也已为人所知,但利用全面的全球数据对这些药物进行心血管风险评估却很有限。本研究利用全球药物警戒数据调查了个别ADHD药物与心血管疾病(CVD)之间的关联:方法:采用世界卫生组织国际药物警戒数据库中的报告(1967-2023 年;报告总数,n=131,255,418)。计算报告几率比(ROR)和信息成分(IC),以评估每种药物与特定心血管疾病之间的关联:结果:在所有关于ADHD药物的146,489例报告中,我们发现了13,344例心血管疾病与ADHD药物有关。自2010年以来,有关ADHD药物的累计报告呈稳步增长趋势,尤其是在成人中。总体而言,ADHD 药物与较高的心血管疾病风险相关(ROR [95 % CI],1.60 [1.58-1.63];IC [IC0.25],0.63 [0.60]),女性的相关性高于男性。在特定的心血管疾病中,所有药物都会增加心肌梗塞/QT延长、心肌病和心肌梗死的风险。相反,心力衰竭、中风和心源性死亡/休克只与苯丙胺类药物有关。与苯丙胺类药物相比,利眠宁与所有心血管疾病的相关性较弱,而哌醋甲酯与心血管疾病的总体相关性最低。阿托莫西汀与心肌梗死/QT延长的相关性位居第二:结论:心血管疾病与多动症药物之间的关联各不相同,苯丙胺类药物的风险较高,而立思辰和哌醋甲酯的安全性较好。
{"title":"Global burden of ADHD medication-associated cardiovascular disease, 1967–2023: A comparative analysis using the WHO pharmacovigilance database","authors":"","doi":"10.1016/j.ajp.2024.104209","DOIUrl":"10.1016/j.ajp.2024.104209","url":null,"abstract":"<div><h3>Background</h3><p>Despite the widespread use of attention-deficit hyperactivity disorder (ADHD) medications and their known sympathomimetic effects on the cardiovascular system, cardiovascular risk assessment of these medications using comprehensive global data is limited. This study investigated the association between individual ADHD medications and cardiovascular disease (CVD) using global pharmacovigilance data.</p></div><div><h3>Methods</h3><p>Reports from the World Health Organization international pharmacovigilance database were utilized (1967–2023; total reports, n=131,255,418). Reporting odds ratios (ROR), and information components (IC) were calculated to evaluate the association between each medication and specific CVDs.</p></div><div><h3>Results</h3><p>We identified 13,344 CVD cases related to ADHD medications out of 146,489 cases of all reports on ADHD medications. Cumulative reports on ADHD medications have shown a steady increase, notably in adults since 2010. ADHD medications were associated with a higher risk of CVD overall (ROR [95 % CI], 1.60 [1.58–1.63]; IC [IC<sub>0.25</sub>], 0.63 [0.60]), with a higher association observed in females than in males. Among specific CVDs, all drugs were associated with an increased risk of torsade de pointes/QT prolongation, cardiomyopathy, and myocardial infarction. Conversely, heart failure, stroke, and cardiac death/shock were exclusively associated with amphetamines. Lisdexamfetamine showed a weaker association with all CVDs compared to amphetamines, and methylphenidate exhibited the lowest overall association with CVD. Atomoxetine had the second-highest association with torsade de pointes/QT prolongation.</p></div><div><h3>Conclusions</h3><p>The associations between CVDs and ADHD medications vary, with amphetamines posing a higher risk, while lisdexamfetamine and methylphenidate exhibit better safety profiles.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142144997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shared deficits of education, marital and occupational functioning in unaffected siblings of multiple affected families with major psychiatric illness 患有重性精神病的多重受影响家庭中未受影响的兄弟姐妹在教育、婚姻和职业功能方面的共同缺陷。
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104216

Background

Major psychiatric illnesses often cluster in families, and their impact on affected and unaffected members within families may reflect the consequence of both genetic and social liability.

Methods

Data was derived from 202 families with multiple affected individuals. Affected individuals (N = 259) had a diagnosis of schizophrenia, bipolar disorder, obsessive-compulsive disorder or substance use disorder. For comparison, we used the unaffected siblings from the same families (N = 229) and a matched random subset of healthy control (HC) data (N = 229) from India’s National Mental Health Survey, 2016 (NMHS). We compared the three groups' educational attainment, functional marital status, and occupational status.

Results

The highest educational attainment was significantly different between the groups. The affected and unaffected siblings had poorer educational attainment compared to HC. Similarly, the affected and unaffected siblings more often remained single, in contrast to HC. Moreover, employment rates were significantly higher in the unaffected siblings, especially female siblings. Overall, females had spent fewer years at school, were primarily married, and were majority homemakers across the three groups compared to males.

Discussion

Affected and unaffected siblings had lower education and marriage rates than HC. The unaffected siblings were more likely to be employed than HC. Whether the poor educational attainment and lower marriage rates in unaffected siblings is a biological marker of shared endophenotype or the effect of the social burden of having an affected family member requires further systematic evaluation.

背景:重大精神疾病往往在家庭中聚集,其对家庭中受影响和未受影响成员的影响可能反映了遗传和社会责任的后果:数据来自 202 个有多名患者的家庭。受影响的个体(N = 259)被诊断为精神分裂症、躁郁症、强迫症或药物使用障碍。为了进行比较,我们使用了同一家庭中未受影响的兄弟姐妹(N = 229)和来自 2016 年印度全国心理健康调查(NMHS)的健康对照(HC)数据的匹配随机子集(N = 229)。我们比较了三组人的受教育程度、功能性婚姻状况和职业状况:各组之间的最高教育程度存在明显差异。与 HC 相比,受影响和未受影响的兄弟姐妹受教育程度较低。同样,与 HC 相比,受影响和未受影响的兄弟姐妹更多地保持单身。此外,未受影响的兄弟姐妹的就业率明显较高,尤其是女性兄弟姐妹。总体而言,与男性相比,女性在三个群体中的就学年数较少,主要是已婚,而且大多数是家庭主妇:讨论:受影响和未受影响的兄弟姐妹的受教育率和结婚率均低于 HC。未受影响的兄弟姐妹比 HC 更有可能就业。未受影响的兄弟姐妹受教育程度低和结婚率低是共同内表型的生物学标志,还是受影响家庭成员的社会负担的影响,这需要进一步的系统评估。
{"title":"Shared deficits of education, marital and occupational functioning in unaffected siblings of multiple affected families with major psychiatric illness","authors":"","doi":"10.1016/j.ajp.2024.104216","DOIUrl":"10.1016/j.ajp.2024.104216","url":null,"abstract":"<div><h3>Background</h3><p>Major psychiatric illnesses often cluster in families, and their impact on affected and unaffected members within families may reflect the consequence of both genetic and social liability.</p></div><div><h3>Methods</h3><p>Data was derived from 202 families with multiple affected individuals. Affected individuals (N = 259) had a diagnosis of schizophrenia, bipolar disorder, obsessive-compulsive disorder or substance use disorder. For comparison, we used the unaffected siblings from the same families (N = 229) and a matched random subset of healthy control (HC) data (N = 229) from India’s National Mental Health Survey, 2016 (NMHS). We compared the three groups' educational attainment, functional marital status, and occupational status.</p></div><div><h3>Results</h3><p>The highest educational attainment was significantly different between the groups. The affected and unaffected siblings had poorer educational attainment compared to HC. Similarly, the affected and unaffected siblings more often remained single, in contrast to HC. Moreover, employment rates were significantly higher in the unaffected siblings, especially female siblings. Overall, females had spent fewer years at school, were primarily married, and were majority homemakers across the three groups compared to males.</p></div><div><h3>Discussion</h3><p>Affected and unaffected siblings had lower education and marriage rates than HC. The unaffected siblings were more likely to be employed than HC. Whether the poor educational attainment and lower marriage rates in unaffected siblings is a biological marker of shared endophenotype or the effect of the social burden of having an affected family member requires further systematic evaluation.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
India’s first child forensics training curriculum and manual on integrating interventions for legal and mental health dimensions of child sexual abuse 印度首个儿童法医培训课程和手册,内容涉及对儿童性虐待的法律和心理健康方面的综合干预。
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104212
{"title":"India’s first child forensics training curriculum and manual on integrating interventions for legal and mental health dimensions of child sexual abuse","authors":"","doi":"10.1016/j.ajp.2024.104212","DOIUrl":"10.1016/j.ajp.2024.104212","url":null,"abstract":"","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142144998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of ECT in patients with organic catatonia 对器质性紧张症患者使用电痉挛疗法。
IF 3.8 4区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-30 DOI: 10.1016/j.ajp.2024.104206

Background

Electroconvulsive therapy (ECT) is considered to be a treatment of choice in patients with catatonia, who do not respond to lorazepam, irrespective of the underlying aetiology. Although, significant data is available for successful use of ECT in patients with catatonia secondary to affective and psychotic disorders, little information is available for use of ECT in organic catatonia.

Aim

To assess demographic and clinical profile of patients with organic catatonia receiving ECT.

Methodology

Using a retrospective study design, ECT register of the department was reviewed for the period of 2019–2023 to identify the patients with organic catatonia, who received ECT. The treatment records of these patients were reviewed to extract the demographic and clinical profile.

Results

During the study period, out of the 926 patients who received ECT, 12 (1.3 %) patients diagnosed with organic catatonia received ECT. The mean age of study sample was 41.67 (SD- 20.68) years and mean number of ECTs given in a course of ECT were 8 (SD- 4.3). In majority of the patients, ECT was considered after the failure of lorazepam challenge test. Majority (75 %) of the patients showed good response to ECT and only 16.67 % of the patients experienced complications during the course of ECT.

Conclusion

ECT is an effective and well-tolerated treatment for organic catatonia.

背景:电休克疗法(ECT)被认为是对劳拉西泮无效的紧张性精神障碍患者的首选治疗方法,无论其潜在病因如何。尽管有大量数据表明,对继发于情感障碍和精神障碍的紧张症患者成功使用了电痉挛疗法,但对器质性紧张症患者使用电痉挛疗法的资料却很少:采用回顾性研究设计,对该部门 2019-2023 年期间的电痉挛疗法登记册进行审查,以确定接受电痉挛疗法的器质性紧张症患者。对这些患者的治疗记录进行审查,以提取人口统计学和临床概况:研究期间,在接受电痉挛疗法的 926 名患者中,有 12 名(1.3%)被诊断为器质性紧张症的患者接受了电痉挛疗法。研究样本的平均年龄为 41.67 岁(SD- 20.68),一个疗程中接受电痉挛疗法的平均次数为 8 次(SD- 4.3)。大多数患者都是在劳拉西泮挑战试验失败后才考虑接受电痉挛疗法。大多数患者(75%)对电痉挛疗法反应良好,只有16.67%的患者在电痉挛疗法过程中出现了并发症:结论:电痉挛疗法是治疗器质性紧张症的一种有效且耐受性良好的方法。
{"title":"Use of ECT in patients with organic catatonia","authors":"","doi":"10.1016/j.ajp.2024.104206","DOIUrl":"10.1016/j.ajp.2024.104206","url":null,"abstract":"<div><h3>Background</h3><p>Electroconvulsive therapy (ECT) is considered to be a treatment of choice in patients with catatonia, who do not respond to lorazepam, irrespective of the underlying aetiology. Although, significant data is available for successful use of ECT in patients with catatonia secondary to affective and psychotic disorders, little information is available for use of ECT in organic catatonia.</p></div><div><h3>Aim</h3><p>To assess demographic and clinical profile of patients with organic catatonia receiving ECT.</p></div><div><h3>Methodology</h3><p>Using a retrospective study design, ECT register of the department was reviewed for the period of 2019–2023 to identify the patients with organic catatonia, who received ECT. The treatment records of these patients were reviewed to extract the demographic and clinical profile.</p></div><div><h3>Results</h3><p>During the study period, out of the 926 patients who received ECT, 12 (1.3 %) patients diagnosed with organic catatonia received ECT. The mean age of study sample was 41.67 (SD- 20.68) years and mean number of ECTs given in a course of ECT were 8 (SD- 4.3). In majority of the patients, ECT was considered after the failure of lorazepam challenge test. Majority (75 %) of the patients showed good response to ECT and only 16.67 % of the patients experienced complications during the course of ECT.</p></div><div><h3>Conclusion</h3><p>ECT is an effective and well-tolerated treatment for organic catatonia.</p></div>","PeriodicalId":8543,"journal":{"name":"Asian journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian journal of psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1